| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 302 |
| 1 | METHOTREXATE | 290 |
| 2 | CYTARABINE | 263 |
| 3 | CYCLOPHOSPHAMIDE | 218 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 218 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 218 |
| 6 | FLUDARABINE PHOSPHATE | 193 |
| 7 | CYCLOSPORINE | 134 |
| 8 | DEXAMETHASONE | 134 |
| 9 | DEXAMETHASONE 1.5 MG | 134 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMIDUBICEL-ONLV | 1 | 0.0455 |
| 1 | OBECABTAGENE AUTOLEUCEL | 2 | 0.0282 |
| 2 | REVUMENIB | 22 | 0.0213 |
| 3 | BETIBEGLOGENE AUTOTEMCEL | 1 | 0.0179 |
| 4 | ARSENIC TRIOXIDE | 37 | 0.0160 |
| 5 | TAGRAXOFUSP | 8 | 0.0149 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 68 | 0.0108 |
| 7 | DASATINIB | 96 | 0.0103 |
| 8 | CLOFARABINE | 23 | 0.0101 |
| 9 | GEMTUZUMAB OZOGAMICIN | 29 | 0.0079 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 355 |
| 1 | Corticosteroid [EPC] | 320 |
| 2 | Alkylating Drug [EPC] | 294 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 290 |
| 4 | Azole Antifungal [EPC] | 137 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 134 |
| 6 | BCL-2 Inhibitor [EPC] | 113 |
| 7 | Kinase Inhibitor [EPC] | 112 |
| 8 | Topoisomerase Inhibitor [EPC] | 95 |
| 9 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 71 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 8 | 0.0149 |
| 1 | CD33-directed Immunoconjugate [EPC] | 29 | 0.0079 |
| 2 | CD22-directed Immunoconjugate [EPC] | 10 | 0.0033 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 48 | 0.0025 |
| 4 | Anthracycline Topoisomerase Inhibitor [EPC] | 6 | 0.0025 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 5 | 0.0023 |
| 6 | BCL-2 Inhibitor [EPC] | 113 | 0.0018 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 18 | 0.0014 |
| 8 | Echinocandin Antifungal [EPC] | 11 | 0.0013 |
| 9 | Asparagine-specific Enzyme [EPC] | 18 | 0.0013 |